07.05.2019
- Through its subsidiary EMD Group Holding II, Germany’s Merck KGaA has agreed to acquire Intermolecular for $1.20 per share, yielding an equity value of $62 million. The US company...
14.04.2019
- Merck KGaA has signed a definitive agreement to acquire Versum Materials for $53 per share in cash after the plans received the green light from the German group’s executive board...
09.04.2019
- Unless something highly unexpected happens, it looks as if Germany’s Merck KGaA has clinched the prize it was seeking, the takeover of US electronics industry supplier Versum...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
27.03.2019
- Merck KGaA is continuing its quest to foil the merger plans of US electronic materials producer Versum with compatriot Entegris and buy Versum itself. The German pharmaceuticals...
13.03.2019
- Turning up the heat in its battle to acquire electronic materials manufacturer Versum, Germany’s Merck KGaA has filed a preliminary proxy statement with the US Securities and...
11.03.2019
- Entegris and Versum Materials continued to hold onto plans for a $4 billion all-stock merger late last week as Germany’s Merck KGaA continued trying to wedge the two US companies...
08.03.2019
- The United States Patent and Trademark Office has granted Germany’s Merck a patent for its proxy-CRISPR technology. This is the Darmstadt-based pharmaceuticals and chemicals...
